We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Whitepapers

Benefits of AGT Culture Media in Gene Therapy Applications content piece image
Whitepaper

Benefits of AGT Culture Media in Gene Therapy Applications

A scalable and robust solution for all stages of the gene therapy workflow to meet regulatory standards is essential, however, as the field is more recent, liquid media is the common format even though it can be more expensive and have a shorter shelf life.
Diving Deep Into Cell Therapy: An Industry Perspective content piece image
Whitepaper

Diving Deep Into Cell Therapy: An Industry Perspective

Active cell therapy drugs represent the latest in cancer treatment. Of these, chimeric antigen receptor (CAR) cell modalities are considered the most successful.
Solid Form Informatics for Pharmaceuticals and Fine Chemicals  content piece image
Whitepaper

Solid Form Informatics for Pharmaceuticals and Fine Chemicals

Solid form informatics (SFI) provides a knowledge-based approach to improve the effectiveness and quality of early-phase drug discovery research, as well as a rational approach to risk assessment.

Enhance the Cost-Effectiveness of Your cGMP Chemical Supply Chain content piece image
Whitepaper

Enhance the Cost-Effectiveness of Your cGMP Chemical Supply Chain

Chemical supply chain issues can have real, quantifiable impacts on biomanufacturers. While the efficient management of storage and inventory can help to reduce risk, it can also prove resource intensive and increase the total cost of ownership.
Discovery of Blood-Based Biomarkers in Neurodegenerative Diseases content piece image
Whitepaper

Discovery of Blood-Based Biomarkers in Neurodegenerative Diseases

The SomaScan Assay is an ideal high throughput platform for identifying proteins that may be involved in disease pathology, as it offers a highly sensitive method of quantifying proteins in different biologic fluids such as serum, plasma, urine and cerebrospinal fluid.
Genetic Insights for Biopharmaceuticals: Propelling Drug Candidates into Therapeutic Assets  content piece image
Whitepaper

Genetic Insights for Biopharmaceuticals: Propelling Drug Candidates into Therapeutic Assets

Innovation is key for any biopharmaceutical and biotechnology company. Whilst the demand for infectious disease prevention continues to grow, so does the pressure on these companies to deliver innovative solutions.
Blurry red dots.
Whitepaper

Performance Evaluation of the Cobas® t 711 Coagulation Analyzer

In this whitepaper, learn how the innovative features of the cobas t 711 coagulation analyzer address the need for greater efficiency, improved workflow and reliable results, potentially allowing laboratory staff to gain more time to focus on validation and clinical interpretation.
Fast, Sensitive and Robust Host Cell Protein Analysis content piece image
Whitepaper

Fast, Sensitive and Robust Host Cell Protein Analysis

Process development teams need detailed information, via a platform that delivers short gradients to allow the required sample throughput to detect HCPs in a low sub-ppm range.
Advanced Flow Cytometry Applications for Antibody, Small Molecule and Phenotypic Screening content piece image
Whitepaper

Advanced Flow Cytometry Applications for Antibody, Small Molecule and Phenotypic Screening

Flow cytometry is an important part of the drug discovery workflow. From screening antibodies to small molecules, combining tests for various analytes in a single panel not only reduces the necessary sample volume but also collects more information in less time, accelerating the drug discovery process.
Updated Air Monitoring Requirements for Medical Device Manufacturers content piece image
Whitepaper

Updated Air Monitoring Requirements for Medical Device Manufacturers

The EU GMP Annex 1 provides specific guidance on the manufacture of sterile medicinal products. Though it is a European guide for manufacturing, EU GMP Annex 1’s impact is global. So how does the latest revision affect you?
Advertisement